Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22
Phase 31
Phase 44

Trial Status

Completed1
Recruiting4
Other5

Role Distribution

Principal Investigator10
PI Rate100%

Activity Timeline

Clinical Trials (10)

NCT06711562Recruiting
Model-informed Individualized Treatment of Anti-infective Drugs
Osteoarticular Infections
PrincipalinvestigatorStart date: 2024-10-12
NCT06711575Recruiting
Model-informed Individualized Treatment of Anti-Infective Drugs in Patients With Spinal Infections
Infectious Diseases of Spine
PrincipalinvestigatorStart date: 2024-10-12
NCT05981079Phase 4Unknown
Model-based Dose Versus Empirical Dose of Piperacillin/Tazobactam in Preterm Neonates With Late-onset Sepsis.
Late-Onset Neonatal Sepsis
PrincipalinvestigatorStart date: 2023-07-31
The Population Pharmacokinetics of Montelukast in Infants and Children
Asthma
PrincipalinvestigatorStart date: 2016-10-01
NCT03844360Phase 4Recruiting
Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease
Hematological Neoplasms
PrincipalinvestigatorStart date: 2016-01-31
NCT03920813Phase 4Unknown
Determinants of Mercaptopurine Toxicity in Paediatric Acute Lymphoblastic Leukemia Maintenance Therapy
Acute Lymphoblastic Leukemia
PrincipalinvestigatorStart date: 2015-01-01
NCT03347357Phase 4Completed
Pharmacokinetics of Tacrolimus in Children
Nephrotic Syndrome
PrincipalinvestigatorStart date: 2012-01-01
NCT04228393Phase 2/3Unknown
The Individualized Treatment of 6-mercaptopurine in Children With Acute Lymphoblastic Leukemia in China
Acute Lymphoblastic Leukemia, Pediatric
Principalinvestigator
NCT06917495Phase 2Not Yet Recruiting
Short-Course Anti-tuberculosis Regimens for Mild Spinal Tuberculosis
Mild Spinal Tuberculosis
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

AsthmaHematologic Neoplasms
Similarity Score6%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Hematologic NeoplasmsPrecursor Cell Lymphoblastic Leukemia-Lymphoma

Worked with same sponsors:

Institute of Hematology & Blood Diseases Hospital, ChinaThe Affiliated Hospital of Qingdao University
Similarity Score6%

Richard W Childs, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Related
15 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaHematologic Neoplasms
Similarity Score6%

Yves Beguin, MD, PhD

CHU-ULg

Related
7 trials

Shared therapeutic areas:

Hematologic NeoplasmsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score6%

Guillermo Garcia-Manero, MD

M.D. Anderson Cancer Center

Related
18 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaHematologic Neoplasms
Similarity Score6%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score3%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score3%

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score3%

Ali MA Ismail, lecturer

Cairo University

Related
27 trials

Shared therapeutic areas:

Asthma
Similarity Score3%

Paula Fernstrom

Nexium Global Product Director, AstraZeneca

Related
18 trials

Shared therapeutic areas:

Asthma
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (10)

Showing 10 of 10 trials

NCT06711562PrincipalInvestigator

Model-informed Individualized Treatment of Anti-infective Drugs

Osteoarticular Infections
Recruiting
NCT06711575PrincipalInvestigator

Model-informed Individualized Treatment of Anti-Infective Drugs in Patients With Spinal Infections

Infectious Diseases of Spine
Recruiting
NCT05981079Phase 4PrincipalInvestigator

Model-based Dose Versus Empirical Dose of Piperacillin/Tazobactam in Preterm Neonates With Late-onset Sepsis.

Late-Onset Neonatal Sepsis
Unknown
NCT03238560PrincipalInvestigator

The Population Pharmacokinetics of Montelukast in Infants and Children

Asthma
Unknown
NCT03844360Phase 4PrincipalInvestigator

Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease

Hematological Neoplasms
Recruiting
NCT03920813Phase 4PrincipalInvestigator

Determinants of Mercaptopurine Toxicity in Paediatric Acute Lymphoblastic Leukemia Maintenance Therapy

Acute Lymphoblastic Leukemia
Unknown
NCT03347357Phase 4PrincipalInvestigator

Pharmacokinetics of Tacrolimus in Children

Nephrotic Syndrome
Completed
NCT04228393Phase 2/3PrincipalInvestigator

The Individualized Treatment of 6-mercaptopurine in Children With Acute Lymphoblastic Leukemia in China

Acute Lymphoblastic Leukemia, Pediatric
Unknown
NCT06076200PrincipalInvestigator

Population Pharmacokinetic of Piperacillin/Tazobactam in Maternal and Neonatal Populations

Early-Onset Neonatal Sepsis
Recruiting
NCT06917495Phase 2PrincipalInvestigator

Short-Course Anti-tuberculosis Regimens for Mild Spinal Tuberculosis

Mild Spinal Tuberculosis
Not Yet Recruiting

All 10 trials loaded